Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hand1
|
ENSMUSG00000037335.7 | heart and neural crest derivatives expressed 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_57832057_57832259 | Hand1 | 11 | 0.972143 | 0.32 | 1.8e-02 | Click! |
chr11_57837001_57837152 | Hand1 | 4258 | 0.181307 | 0.32 | 1.8e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr4_20777672_20778960 | 19.03 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr19_38054215_38055320 | 15.50 |
I830134H01Rik |
RIKEN cDNA I830134H01 gene |
239 |
0.48 |
chr9_25526878_25527361 | 14.66 |
Gm25861 |
predicted gene, 25861 |
12086 |
0.2 |
chr14_14350947_14351733 | 13.42 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chr7_79148252_79148910 | 12.35 |
Mfge8 |
milk fat globule-EGF factor 8 protein |
350 |
0.87 |
chr7_130977605_130978173 | 12.24 |
Htra1 |
HtrA serine peptidase 1 |
3781 |
0.24 |
chr12_113132495_113133476 | 12.08 |
Mta1 |
metastasis associated 1 |
1437 |
0.26 |
chr9_54784115_54784302 | 11.81 |
Crabp1 |
cellular retinoic acid binding protein I |
19460 |
0.14 |
chr5_133385739_133386398 | 11.65 |
Gm42625 |
predicted gene 42625 |
57274 |
0.15 |
chr15_101147926_101148256 | 11.56 |
Acvrl1 |
activin A receptor, type II-like 1 |
10491 |
0.11 |
chr7_16876576_16877253 | 11.51 |
Dact3 |
dishevelled-binding antagonist of beta-catenin 3 |
1597 |
0.18 |
chr11_108947494_108948034 | 11.35 |
Axin2 |
axin 2 |
4143 |
0.23 |
chr14_46885106_46885668 | 11.29 |
2810457G06Rik |
RIKEN cDNA 2810457G06 gene |
323 |
0.74 |
chrX_81070276_81071390 | 11.23 |
Tmem47 |
transmembrane protein 47 |
117 |
0.98 |
chr6_134439509_134440341 | 11.10 |
Gm44448 |
predicted gene, 44448 |
15572 |
0.15 |
chrX_143543266_143543620 | 10.94 |
Pak3 |
p21 (RAC1) activated kinase 3 |
24745 |
0.25 |
chr12_3236518_3237725 | 10.82 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr13_55963309_55963505 | 10.67 |
Gm47071 |
predicted gene, 47071 |
38858 |
0.14 |
chr6_91200670_91201210 | 10.63 |
4930402H05Rik |
RIKEN cDNA 4930402H05 gene |
9104 |
0.14 |
chr8_25343429_25343737 | 10.57 |
5430421F17Rik |
RIKEN cDNA 5430421F17 gene |
37313 |
0.12 |
chr16_14265466_14265813 | 10.47 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr11_32925157_32925655 | 10.26 |
Gm12111 |
predicted gene 12111 |
754 |
0.63 |
chr9_124439906_124440949 | 10.18 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr5_100108777_100109262 | 10.11 |
Tmem150c |
transmembrane protein 150C |
13777 |
0.15 |
chr1_192851641_192852074 | 10.04 |
Sertad4 |
SERTA domain containing 4 |
110 |
0.94 |
chr10_118102987_118104071 | 9.89 |
5330439M10Rik |
RIKEN cDNA 5330439M10 gene |
8988 |
0.17 |
chr4_40798953_40799459 | 9.74 |
Psenen-ps |
presenilin enhancer gamma secretase subunit, pseudogene |
23642 |
0.11 |
chr14_25978756_25979338 | 9.54 |
Duxbl1 |
double homeobox B-like 1 |
36 |
0.96 |
chr4_141011762_141012413 | 9.41 |
Mfap2 |
microfibrillar-associated protein 2 |
1443 |
0.27 |
chr3_139885937_139886924 | 9.36 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr4_54470200_54470449 | 9.34 |
Tpt1-ps2 |
tumor protein, translationally-controlled, pseudogene 2 |
94299 |
0.08 |
chr19_36534720_36535517 | 9.31 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
19521 |
0.2 |
chr5_135877869_135878054 | 9.17 |
Gm22450 |
predicted gene, 22450 |
2304 |
0.17 |
chr4_63084541_63084938 | 9.07 |
Zfp618 |
zinc finger protein 618 |
35661 |
0.16 |
chr14_26258147_26258708 | 9.06 |
Duxbl3 |
double homeobox B-like 3 |
41 |
0.96 |
chr4_114818962_114819553 | 9.04 |
Gm12830 |
predicted gene 12830 |
2465 |
0.28 |
chr17_24736037_24737110 | 9.00 |
Msrb1 |
methionine sulfoxide reductase B1 |
69 |
0.91 |
chr17_35836572_35837313 | 8.89 |
Tubb5 |
tubulin, beta 5 class I |
118 |
0.89 |
chr10_80826008_80827091 | 8.86 |
Oaz1 |
ornithine decarboxylase antizyme 1 |
107 |
0.9 |
chr12_105453716_105453942 | 8.82 |
D430019H16Rik |
RIKEN cDNA D430019H16 gene |
27 |
0.98 |
chr10_13446842_13447237 | 8.65 |
Phactr2 |
phosphatase and actin regulator 2 |
27373 |
0.19 |
chr2_4436351_4436936 | 8.58 |
Gm13175 |
predicted gene 13175 |
30027 |
0.16 |
chr2_136387430_136388483 | 8.56 |
Pak7 |
p21 (RAC1) activated kinase 7 |
4 |
0.98 |
chr3_121588840_121589464 | 8.56 |
A730020M07Rik |
RIKEN cDNA A730020M07 gene |
54215 |
0.09 |
chr13_15212343_15212535 | 8.54 |
Gm9512 |
predicted gene 9512 |
93807 |
0.08 |
chr4_58670580_58670950 | 8.37 |
Gm12580 |
predicted gene 12580 |
12173 |
0.22 |
chr4_110050502_110051534 | 8.36 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
72965 |
0.11 |
chr2_119814487_119814869 | 8.33 |
Tyro3 |
TYRO3 protein tyrosine kinase 3 |
3832 |
0.16 |
chr1_75289710_75289861 | 8.32 |
Resp18 |
regulated endocrine-specific protein 18 |
11370 |
0.08 |
chr19_5071354_5072731 | 8.25 |
Tmem151a |
transmembrane protein 151A |
90 |
0.61 |
chr8_4492910_4494136 | 8.22 |
Cers4 |
ceramide synthase 4 |
2 |
0.97 |
chr10_31173126_31173598 | 8.22 |
Gm23790 |
predicted gene, 23790 |
9730 |
0.2 |
chr4_100828805_100829009 | 8.21 |
Cachd1 |
cache domain containing 1 |
52232 |
0.16 |
chr8_105320451_105321442 | 8.19 |
Lrrc29 |
leucine rich repeat containing 29 |
5313 |
0.07 |
chr7_82715385_82716009 | 8.18 |
Gm44916 |
predicted gene 44916 |
105 |
0.95 |
chr3_120898327_120898653 | 8.11 |
6530403H02Rik |
RIKEN cDNA 6530403H02 gene |
11757 |
0.27 |
chr7_89908523_89908738 | 8.10 |
Ccdc81 |
coiled-coil domain containing 81 |
5001 |
0.17 |
chr1_127537308_127537666 | 8.05 |
Tmem163 |
transmembrane protein 163 |
57 |
0.98 |
chr1_133226926_133227325 | 8.04 |
Plekha6 |
pleckstrin homology domain containing, family A member 6 |
18972 |
0.15 |
chr5_74387255_74387765 | 8.03 |
Scfd2 |
Sec1 family domain containing 2 |
10228 |
0.16 |
chr1_85600326_85601326 | 7.94 |
Sp140 |
Sp140 nuclear body protein |
123 |
0.9 |
chr1_30060918_30061109 | 7.81 |
Gm23771 |
predicted gene, 23771 |
75079 |
0.12 |
chr7_24883912_24885132 | 7.79 |
Rps19 |
ribosomal protein S19 |
111 |
0.92 |
chr11_35625617_35625856 | 7.78 |
Mir218-2 |
microRNA 218-2 |
8920 |
0.26 |
chr10_78464271_78465733 | 7.75 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr5_29826796_29827181 | 7.72 |
Gm1969 |
predicted gene 1969 |
6319 |
0.16 |
chr11_66265191_66265342 | 7.72 |
Dnah9 |
dynein, axonemal, heavy chain 9 |
96715 |
0.08 |
chr8_70315603_70316677 | 7.65 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr7_51955450_51955660 | 7.64 |
Gas2 |
growth arrest specific 2 |
11871 |
0.19 |
chr9_112130902_112131109 | 7.64 |
Mir128-2 |
microRNA 128-2 |
12294 |
0.24 |
chr2_145859511_145860521 | 7.62 |
Rin2 |
Ras and Rab interactor 2 |
2628 |
0.24 |
chr3_80802510_80803270 | 7.54 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr4_142239299_142240110 | 7.44 |
Kazn |
kazrin, periplakin interacting protein |
303 |
0.92 |
chr1_85270214_85271524 | 7.43 |
C130026I21Rik |
RIKEN cDNA C130026I21 gene |
303 |
0.81 |
chr8_112906520_112907100 | 7.40 |
Gm45904 |
predicted gene 45904 |
98187 |
0.08 |
chr18_79051120_79051475 | 7.39 |
Setbp1 |
SET binding protein 1 |
58094 |
0.16 |
chr7_16134462_16134875 | 7.36 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4320 |
0.14 |
chr18_69796023_69796378 | 7.32 |
Tcf4 |
transcription factor 4 |
113820 |
0.06 |
chr11_57600613_57600953 | 7.32 |
Gm12243 |
predicted gene 12243 |
28271 |
0.14 |
chr9_7960251_7960732 | 7.30 |
Yap1 |
yes-associated protein 1 |
5330 |
0.18 |
chr3_121469151_121469626 | 7.30 |
Slc44a3 |
solute carrier family 44, member 3 |
8477 |
0.15 |
chr2_33753581_33754617 | 7.28 |
Mvb12b |
multivesicular body subunit 12B |
34660 |
0.14 |
chr7_49262055_49262574 | 7.27 |
Nav2 |
neuron navigator 2 |
15469 |
0.22 |
chr13_41729696_41729998 | 7.27 |
Adtrp |
androgen dependent TFPI regulating protein |
70719 |
0.08 |
chr3_104790339_104791400 | 7.26 |
Rhoc |
ras homolog family member C |
1114 |
0.3 |
chr2_32317120_32318698 | 7.24 |
Gm23363 |
predicted gene, 23363 |
356 |
0.45 |
chr2_152048577_152049360 | 7.24 |
AA387200 |
expressed sequence AA387200 |
27840 |
0.11 |
chr13_99459018_99459548 | 7.22 |
Map1b |
microtubule-associated protein 1B |
11663 |
0.18 |
chr6_55505206_55505360 | 7.22 |
Gm44352 |
predicted gene, 44352 |
28223 |
0.18 |
chr8_71374903_71376449 | 7.18 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
114 |
0.92 |
chr14_28954666_28954829 | 7.17 |
Cacna2d3 |
calcium channel, voltage-dependent, alpha2/delta subunit 3 |
14666 |
0.22 |
chr15_25762370_25762744 | 7.13 |
Myo10 |
myosin X |
3772 |
0.28 |
chr12_56458764_56459233 | 7.12 |
Sfta3-ps |
surfactant associated 3, pseudogene |
34326 |
0.12 |
chr14_8952976_8953147 | 7.12 |
Gm18071 |
predicted gene, 18071 |
26881 |
0.24 |
chr9_29025762_29025914 | 7.11 |
Ntm |
neurotrimin |
11579 |
0.24 |
chr5_134014531_134015255 | 7.06 |
1700030N18Rik |
RIKEN cDNA 1700030N18 gene |
76558 |
0.08 |
chr12_85436502_85436773 | 6.98 |
Gm40477 |
predicted gene, 40477 |
388 |
0.82 |
chr14_26118223_26119106 | 6.96 |
Duxbl2 |
double homeobox B-like 2 |
191 |
0.91 |
chr13_107767262_107767617 | 6.96 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr6_55388308_55389212 | 6.92 |
6430584L05Rik |
RIKEN cDNA 6430584L05 gene |
8127 |
0.17 |
chr7_30291145_30292058 | 6.90 |
Clip3 |
CAP-GLY domain containing linker protein 3 |
127 |
0.89 |
chr17_70755751_70755934 | 6.90 |
5031415H12Rik |
RIKEN cDNA 5031415H12 gene |
260 |
0.91 |
chr10_86211993_86212399 | 6.89 |
Gm15990 |
predicted gene 15990 |
86369 |
0.06 |
chr9_17289080_17289487 | 6.87 |
Gm2594 |
predicted gene 2594 |
213426 |
0.02 |
chr1_165281854_165282892 | 6.84 |
Gpr161 |
G protein-coupled receptor 161 |
13416 |
0.16 |
chr3_9173889_9174631 | 6.78 |
Zbtb10 |
zinc finger and BTB domain containing 10 |
76342 |
0.09 |
chr5_130623231_130623604 | 6.76 |
Gm43418 |
predicted gene 43418 |
4866 |
0.31 |
chr10_122912730_122913440 | 6.73 |
Ppm1h |
protein phosphatase 1H (PP2C domain containing) |
17717 |
0.2 |
chr17_45734818_45735476 | 6.73 |
F630040K05Rik |
RIKEN cDNA F630040K05 gene |
641 |
0.55 |
chr13_113663169_113663465 | 6.73 |
Hspb3 |
heat shock protein 3 |
359 |
0.85 |
chr11_116922084_116922377 | 6.73 |
Mgat5b |
mannoside acetylglucosaminyltransferase 5, isoenzyme B |
3367 |
0.2 |
chr5_112228050_112228579 | 6.72 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
327 |
0.82 |
chr9_122836785_122837126 | 6.71 |
Gm35549 |
predicted gene, 35549 |
6931 |
0.11 |
chr10_20286388_20286827 | 6.70 |
Gm48249 |
predicted gene, 48249 |
19 |
0.96 |
chr8_71569766_71570805 | 6.68 |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
113 |
0.9 |
chr9_8900765_8902148 | 6.67 |
Pgr |
progesterone receptor |
988 |
0.68 |
chr4_109977849_109978740 | 6.65 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr11_36678120_36678295 | 6.63 |
Tenm2 |
teneurin transmembrane protein 2 |
462 |
0.88 |
chr10_59089858_59090131 | 6.60 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
9960 |
0.24 |
chr16_52134647_52134858 | 6.57 |
Cblb |
Casitas B-lineage lymphoma b |
17774 |
0.23 |
chr2_17839635_17839891 | 6.57 |
Gm13323 |
predicted gene 13323 |
41779 |
0.17 |
chr19_16868645_16868854 | 6.56 |
Gm32341 |
predicted gene, 32341 |
2343 |
0.3 |
chr11_69559283_69560047 | 6.54 |
Efnb3 |
ephrin B3 |
540 |
0.54 |
chr9_37114956_37115270 | 6.46 |
Gm48716 |
predicted gene, 48716 |
3543 |
0.18 |
chr1_73758738_73758957 | 6.45 |
Gm25329 |
predicted gene, 25329 |
4863 |
0.23 |
chr4_98223390_98223614 | 6.45 |
Gm12692 |
predicted gene 12692 |
11788 |
0.21 |
chr4_68954543_68954884 | 6.45 |
Brinp1 |
bone morphogenic protein/retinoic acid inducible neural specific 1 |
316 |
0.95 |
chr1_192785556_192785974 | 6.43 |
Hhat |
hedgehog acyltransferase |
14542 |
0.15 |
chr16_21204017_21204813 | 6.41 |
Ephb3 |
Eph receptor B3 |
340 |
0.87 |
chr15_82983151_82983317 | 6.41 |
Gm29019 |
predicted gene 29019 |
4478 |
0.15 |
chr1_155233440_155234889 | 6.41 |
BC034090 |
cDNA sequence BC034090 |
1253 |
0.38 |
chr4_13833050_13833229 | 6.41 |
Runx1t1 |
RUNX1 translocation partner 1 |
48357 |
0.18 |
chr2_12709166_12709591 | 6.40 |
Gm37565 |
predicted gene, 37565 |
11961 |
0.29 |
chr1_75925868_75926094 | 6.39 |
Gm29065 |
predicted gene 29065 |
92775 |
0.08 |
chr15_83781373_83781535 | 6.37 |
Mpped1 |
metallophosphoesterase domain containing 1 |
1431 |
0.48 |
chrX_106898018_106898169 | 6.35 |
Lpar4 |
lysophosphatidic acid receptor 4 |
22532 |
0.19 |
chr2_103690399_103690929 | 6.35 |
Abtb2 |
ankyrin repeat and BTB (POZ) domain containing 2 |
24371 |
0.15 |
chr3_134629851_134630075 | 6.35 |
Gm26820 |
predicted gene, 26820 |
802 |
0.76 |
chr4_72800139_72800290 | 6.34 |
Aldoart1 |
aldolase 1 A, retrogene 1 |
52418 |
0.16 |
chr6_4994771_4994952 | 6.34 |
Gm26556 |
predicted gene, 26556 |
35878 |
0.14 |
chr5_137313761_137314590 | 6.34 |
Trip6 |
thyroid hormone receptor interactor 6 |
11 |
0.94 |
chr15_37672637_37672815 | 6.33 |
Gm15942 |
predicted gene 15942 |
27978 |
0.15 |
chr13_51221189_51221440 | 6.31 |
Gm29787 |
predicted gene, 29787 |
15203 |
0.15 |
chr7_135965549_135965700 | 6.31 |
Gm9341 |
predicted gene 9341 |
12826 |
0.22 |
chr18_54091417_54091774 | 6.30 |
Gm8594 |
predicted gene 8594 |
60287 |
0.14 |
chr15_37790660_37790811 | 6.30 |
Ncald |
neurocalcin delta |
1265 |
0.44 |
chr6_94773287_94774569 | 6.28 |
Gm43997 |
predicted gene, 43997 |
25504 |
0.15 |
chr15_77037711_77038357 | 6.27 |
Apol6 |
apolipoprotein L 6 |
6695 |
0.11 |
chr1_59269990_59270338 | 6.27 |
Cdk15 |
cyclin-dependent kinase 15 |
13036 |
0.18 |
chr16_29839221_29839811 | 6.26 |
Gm32679 |
predicted gene, 32679 |
4788 |
0.23 |
chr17_15829472_15830199 | 6.25 |
Rgmb |
repulsive guidance molecule family member B |
816 |
0.55 |
chr7_141468254_141469266 | 6.23 |
Cd151 |
CD151 antigen |
62 |
0.89 |
chr4_54646478_54646629 | 6.23 |
Gm12478 |
predicted gene 12478 |
11 |
0.79 |
chr9_97685863_97686014 | 6.22 |
Gm37661 |
predicted gene, 37661 |
244217 |
0.02 |
chr3_98338997_98340095 | 6.22 |
Phgdh |
3-phosphoglycerate dehydrogenase |
444 |
0.81 |
chr16_42781642_42782072 | 6.22 |
4932412D23Rik |
RIKEN cDNA 4932412D23 gene |
93730 |
0.08 |
chr19_22905041_22905207 | 6.22 |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
138490 |
0.04 |
chr9_98645825_98646021 | 6.20 |
Mrps22 |
mitochondrial ribosomal protein S22 |
44263 |
0.1 |
chr1_155504684_155504880 | 6.19 |
Gm5532 |
predicted gene 5532 |
22329 |
0.2 |
chr17_32810212_32810391 | 6.19 |
Gm26693 |
predicted gene, 26693 |
157 |
0.7 |
chr18_61692296_61692680 | 6.18 |
Gm38165 |
predicted gene, 38165 |
104 |
0.94 |
chr16_58349503_58349654 | 6.17 |
Gm37825 |
predicted gene, 37825 |
30507 |
0.17 |
chr10_79636972_79637781 | 6.17 |
Gm47163 |
predicted gene, 47163 |
480 |
0.42 |
chr12_109437549_109438231 | 6.16 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
14933 |
0.1 |
chr1_81594178_81594459 | 6.15 |
Gm6198 |
predicted gene 6198 |
36835 |
0.2 |
chr1_13835151_13835327 | 6.15 |
Gm36947 |
predicted gene, 36947 |
13880 |
0.22 |
chr7_93094246_93094397 | 6.14 |
Gm9934 |
predicted gene 9934 |
13294 |
0.16 |
chr4_82762467_82762760 | 6.14 |
Nfib |
nuclear factor I/B |
56863 |
0.12 |
chr8_71379428_71380688 | 6.13 |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
851 |
0.4 |
chr16_86067694_86067845 | 6.13 |
Gm49570 |
predicted gene, 49570 |
52314 |
0.16 |
chr1_88254702_88255947 | 6.13 |
Mroh2a |
maestro heat-like repeat family member 2A |
2434 |
0.15 |
chr1_171252075_171252274 | 6.13 |
Adamts4 |
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 4 |
58 |
0.89 |
chr11_61453382_61453704 | 6.12 |
Rnf112 |
ring finger protein 112 |
376 |
0.79 |
chr3_101395397_101395703 | 6.11 |
Gm42939 |
predicted gene 42939 |
12243 |
0.14 |
chr19_36129658_36129991 | 6.08 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
9725 |
0.19 |
chr12_3891760_3892416 | 6.08 |
Dnmt3a |
DNA methyltransferase 3A |
344 |
0.86 |
chr5_149320439_149321321 | 6.07 |
Gm19719 |
predicted gene, 19719 |
33012 |
0.08 |
chr8_30946439_30946595 | 6.07 |
Gm45252 |
predicted gene 45252 |
57391 |
0.14 |
chr1_89183290_89183867 | 6.06 |
Gm5259 |
predicted gene 5259 |
73403 |
0.09 |
chr17_44618291_44618521 | 6.05 |
n-R5s27 |
nuclear encoded rRNA 5S 27 |
22737 |
0.2 |
chr10_106632222_106632491 | 6.05 |
4930532I03Rik |
RIKEN cDNA 4930532I03 gene |
29876 |
0.23 |
chr7_7187920_7188121 | 6.04 |
Zfp418 |
zinc finger protein 418 |
16666 |
0.1 |
chr5_93266876_93267277 | 6.02 |
Ccng2 |
cyclin G2 |
181 |
0.95 |
chr9_41579727_41580423 | 6.01 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
97 |
0.93 |
chr19_33068392_33068576 | 6.00 |
Gm29863 |
predicted gene, 29863 |
1588 |
0.46 |
chr11_3374518_3374669 | 6.00 |
Limk2 |
LIM motif-containing protein kinase 2 |
3217 |
0.16 |
chr8_36142092_36142588 | 6.00 |
Gm38414 |
predicted gene, 38414 |
13670 |
0.15 |
chr1_37122281_37122432 | 5.99 |
Gm37020 |
predicted gene, 37020 |
10908 |
0.19 |
chr1_192789049_192789578 | 5.98 |
Hhat |
hedgehog acyltransferase |
18090 |
0.14 |
chrX_102003725_102004324 | 5.97 |
Nhsl2 |
NHS-like 2 |
1020 |
0.5 |
chr15_27788001_27788934 | 5.96 |
Trio |
triple functional domain (PTPRF interacting) |
171 |
0.96 |
chr18_17391095_17391251 | 5.96 |
4921533I20Rik |
Riken cDNA 4921533I20 gene |
71443 |
0.13 |
chr6_100503301_100503752 | 5.96 |
Gm44107 |
predicted gene, 44107 |
5011 |
0.19 |
chr14_8250237_8250530 | 5.96 |
Acox2 |
acyl-Coenzyme A oxidase 2, branched chain |
3139 |
0.25 |
chr5_112239158_112239879 | 5.93 |
Miat |
myocardial infarction associated transcript (non-protein coding) |
10123 |
0.11 |
chr14_122607548_122607718 | 5.93 |
Gm49259 |
predicted gene, 49259 |
2480 |
0.27 |
chr17_28037288_28037553 | 5.92 |
Anks1 |
ankyrin repeat and SAM domain containing 1 |
3355 |
0.16 |
chr17_52601056_52601789 | 5.91 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr11_32001599_32001931 | 5.90 |
Nsg2 |
neuron specific gene family member 2 |
1263 |
0.5 |
chr19_59542145_59542347 | 5.90 |
Gm18161 |
predicted gene, 18161 |
1795 |
0.38 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 15.1 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
3.9 | 15.6 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
3.8 | 18.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
3.6 | 7.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
3.5 | 10.6 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
3.5 | 10.5 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
3.5 | 10.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.4 | 10.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
3.3 | 13.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
3.2 | 9.5 | GO:0033058 | directional locomotion(GO:0033058) |
3.2 | 9.5 | GO:0021564 | vagus nerve development(GO:0021564) |
3.1 | 6.2 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.1 | 3.1 | GO:0021827 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
3.0 | 21.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.0 | 8.9 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.9 | 2.9 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
2.9 | 32.0 | GO:0071625 | vocalization behavior(GO:0071625) |
2.8 | 8.4 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
2.8 | 5.5 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
2.8 | 2.8 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
2.7 | 8.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
2.7 | 8.1 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
2.7 | 8.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.7 | 10.7 | GO:0030091 | protein repair(GO:0030091) |
2.7 | 50.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
2.6 | 7.7 | GO:2000598 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.6 | 10.3 | GO:0003139 | secondary heart field specification(GO:0003139) |
2.5 | 10.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
2.5 | 9.9 | GO:0035989 | tendon development(GO:0035989) |
2.4 | 7.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.4 | 2.4 | GO:1901321 | positive regulation of heart induction(GO:1901321) |
2.4 | 7.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
2.4 | 7.1 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
2.3 | 7.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
2.3 | 4.7 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
2.2 | 6.7 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
2.2 | 13.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
2.2 | 4.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
2.2 | 6.6 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
2.2 | 4.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
2.2 | 10.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
2.1 | 4.3 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
2.1 | 4.3 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
2.1 | 4.3 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.1 | 4.1 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
2.1 | 4.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
2.0 | 6.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.0 | 4.1 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.0 | 6.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
2.0 | 6.0 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
2.0 | 2.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.0 | 4.0 | GO:0038091 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
1.9 | 9.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
1.9 | 1.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
1.9 | 5.8 | GO:0072240 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.9 | 13.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.9 | 17.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
1.9 | 1.9 | GO:0021586 | pons maturation(GO:0021586) |
1.9 | 5.6 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
1.9 | 3.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.9 | 15.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.9 | 1.9 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.8 | 3.7 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
1.8 | 5.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.8 | 16.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.8 | 1.8 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) |
1.8 | 5.4 | GO:0061743 | motor learning(GO:0061743) |
1.8 | 21.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.8 | 5.4 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
1.8 | 7.1 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.7 | 7.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
1.7 | 3.5 | GO:0046959 | habituation(GO:0046959) |
1.7 | 8.6 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
1.7 | 5.1 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.7 | 5.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.7 | 3.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.7 | 8.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.7 | 6.7 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
1.7 | 5.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.7 | 3.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
1.6 | 3.3 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.6 | 4.9 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.6 | 3.2 | GO:0008355 | olfactory learning(GO:0008355) |
1.6 | 6.3 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.6 | 4.7 | GO:0010288 | response to lead ion(GO:0010288) |
1.6 | 7.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.6 | 12.5 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
1.6 | 4.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.6 | 10.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
1.6 | 1.6 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.5 | 7.7 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.5 | 15.4 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.5 | 3.1 | GO:0001757 | somite specification(GO:0001757) |
1.5 | 4.6 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.5 | 4.6 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
1.5 | 4.5 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
1.5 | 3.0 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
1.5 | 11.9 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
1.5 | 3.0 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.5 | 1.5 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.5 | 5.9 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
1.5 | 5.9 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.5 | 1.5 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
1.5 | 4.4 | GO:0002278 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
1.5 | 16.2 | GO:0003417 | growth plate cartilage development(GO:0003417) |
1.5 | 5.9 | GO:0021747 | cochlear nucleus development(GO:0021747) |
1.4 | 2.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
1.4 | 5.8 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
1.4 | 4.3 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
1.4 | 7.2 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
1.4 | 4.3 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.4 | 1.4 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
1.4 | 2.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.4 | 4.2 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
1.4 | 4.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
1.4 | 5.6 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.4 | 12.5 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.4 | 1.4 | GO:0003166 | bundle of His development(GO:0003166) positive regulation of cardioblast differentiation(GO:0051891) |
1.4 | 4.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.4 | 1.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.4 | 6.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.3 | 4.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
1.3 | 4.0 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
1.3 | 8.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
1.3 | 5.3 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.3 | 10.6 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
1.3 | 4.0 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
1.3 | 4.0 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.3 | 3.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.3 | 44.7 | GO:0019228 | neuronal action potential(GO:0019228) |
1.3 | 6.6 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
1.3 | 1.3 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
1.3 | 2.6 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
1.3 | 3.9 | GO:1990035 | calcium ion import into cell(GO:1990035) |
1.3 | 5.1 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.3 | 1.3 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
1.3 | 3.8 | GO:1903423 | positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
1.3 | 3.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
1.3 | 8.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.2 | 1.2 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) endodermal digestive tract morphogenesis(GO:0061031) |
1.2 | 4.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.2 | 2.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.2 | 3.7 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
1.2 | 18.3 | GO:0001964 | startle response(GO:0001964) |
1.2 | 6.1 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.2 | 3.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.2 | 4.8 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
1.2 | 3.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.2 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.2 | 4.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.2 | 7.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.2 | 3.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.2 | 1.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
1.2 | 8.3 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
1.2 | 1.2 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.2 | 3.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.2 | 1.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.2 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
1.2 | 4.6 | GO:0048664 | neuron fate determination(GO:0048664) |
1.1 | 3.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
1.1 | 3.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
1.1 | 3.4 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
1.1 | 3.4 | GO:0060594 | mammary gland specification(GO:0060594) |
1.1 | 3.4 | GO:1904180 | negative regulation of membrane depolarization(GO:1904180) |
1.1 | 2.2 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
1.1 | 2.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.1 | 3.3 | GO:0090135 | actin filament branching(GO:0090135) |
1.1 | 7.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
1.1 | 8.8 | GO:0071420 | response to histamine(GO:0034776) cellular response to histamine(GO:0071420) |
1.1 | 3.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.1 | 4.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
1.1 | 1.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.1 | 5.4 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.1 | 63.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.1 | 6.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
1.1 | 10.7 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
1.1 | 3.2 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 1.1 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.1 | 4.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.0 | 1.0 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.0 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.0 | 5.2 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
1.0 | 2.1 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 5.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
1.0 | 7.2 | GO:0097264 | self proteolysis(GO:0097264) |
1.0 | 5.1 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 2.0 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.0 | 5.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.0 | 3.0 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
1.0 | 2.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.0 | 1.0 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 2.9 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
1.0 | 2.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.0 | 1.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.0 | 2.9 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
1.0 | 5.8 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 6.8 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.0 | 1.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.0 | 2.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
1.0 | 1.9 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.0 | 2.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 2.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
1.0 | 2.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.0 | 10.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.0 | 5.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.0 | 1.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.0 | 2.9 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.0 | 4.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.9 | 0.9 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
0.9 | 1.9 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.9 | 3.7 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.9 | 0.9 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
0.9 | 1.8 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) |
0.9 | 2.6 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.9 | 1.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
0.9 | 0.9 | GO:0021558 | trochlear nerve development(GO:0021558) |
0.9 | 0.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.9 | 2.6 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.9 | 3.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.9 | 1.7 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.9 | 2.6 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.9 | 1.7 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.8 | 1.7 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.8 | 0.8 | GO:2000729 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.8 | 1.7 | GO:0021554 | optic nerve development(GO:0021554) |
0.8 | 12.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.8 | 2.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.8 | 0.8 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 6.6 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.8 | 1.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.8 | 0.8 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.8 | 3.3 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
0.8 | 0.8 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 2.5 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.8 | 5.7 | GO:0008038 | neuron recognition(GO:0008038) |
0.8 | 0.8 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.8 | 2.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.8 | 5.7 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.8 | 9.7 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.8 | 4.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.8 | 6.4 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.8 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 4.7 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.8 | 4.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 3.2 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.8 | 12.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.8 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
0.8 | 7.8 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.8 | 3.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.8 | 1.6 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
0.8 | 3.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.8 | 0.8 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.8 | 7.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.8 | 1.5 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.8 | 0.8 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.8 | 6.1 | GO:0060736 | prostate gland growth(GO:0060736) |
0.8 | 0.8 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.8 | 3.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.8 | 3.0 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.8 | 6.8 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.8 | 3.8 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 3.0 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.8 | 1.5 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.7 | 0.7 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.7 | 1.5 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.7 | 0.7 | GO:0060174 | limb bud formation(GO:0060174) |
0.7 | 0.7 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.7 | 1.5 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.7 | 4.4 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 2.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.7 | 2.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.7 | 3.6 | GO:0060482 | lobar bronchus development(GO:0060482) |
0.7 | 2.9 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.7 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.7 | 1.4 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.7 | 2.2 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.7 | 52.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.7 | 3.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.7 | 0.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.7 | 10.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.7 | 2.9 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.7 | 2.1 | GO:0030070 | insulin processing(GO:0030070) |
0.7 | 10.7 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.7 | 2.8 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.7 | 1.4 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.7 | 12.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.7 | 2.1 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.7 | 3.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.7 | 2.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 2.8 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 2.8 | GO:0015822 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.7 | 2.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.7 | 4.9 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.7 | 0.7 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.7 | 5.5 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.7 | 0.7 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.7 | 1.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.7 | 1.4 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.7 | 3.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 1.4 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 0.7 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.7 | 0.7 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.7 | 12.2 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.7 | 10.1 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.7 | 2.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.7 | 1.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.7 | 2.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 1.3 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 2.0 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.7 | 2.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 4.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.7 | 2.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.7 | 2.0 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.7 | 0.7 | GO:0035799 | ureter maturation(GO:0035799) |
0.6 | 1.3 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 8.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.6 | 0.6 | GO:0030421 | defecation(GO:0030421) |
0.6 | 0.6 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
0.6 | 3.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 1.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.6 | 0.6 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.6 | 1.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 1.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.6 | 3.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.6 | 1.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.6 | 1.2 | GO:1902688 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
0.6 | 3.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.6 | 6.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 4.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.6 | 1.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.6 | 1.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.6 | 1.2 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.6 | 1.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.6 | 10.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.6 | 2.3 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.6 | 1.7 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.6 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.6 | 1.7 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.6 | 0.6 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.6 | 2.3 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.6 | 2.3 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.6 | 1.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.6 | 1.7 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.6 | 0.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 0.6 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.6 | 1.7 | GO:1901162 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.6 | 2.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.6 | 0.6 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.6 | 1.1 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.6 | 1.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.5 | 1.1 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.5 | 1.6 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.5 | 4.9 | GO:0060074 | synapse maturation(GO:0060074) |
0.5 | 7.1 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.5 | 1.1 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.5 | 2.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 2.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.5 | 3.8 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.5 | 5.4 | GO:1990403 | embryonic brain development(GO:1990403) |
0.5 | 0.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.5 | 1.6 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 0.5 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.5 | 1.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.5 | 0.5 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.5 | 1.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 2.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.5 | 0.5 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.5 | 0.5 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.5 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 1.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.5 | 1.0 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.5 | 1.5 | GO:0097503 | sialylation(GO:0097503) |
0.5 | 1.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.5 | 1.5 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.5 | 1.5 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.5 | 2.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.5 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.5 | 1.0 | GO:0060166 | olfactory pit development(GO:0060166) |
0.5 | 2.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.5 | 1.5 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.5 | 2.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.5 | 1.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.5 | 1.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 1.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.5 | 1.0 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 1.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 2.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.5 | 2.4 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.5 | 5.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.5 | 1.0 | GO:0060384 | innervation(GO:0060384) |
0.5 | 0.5 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.5 | 0.9 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.5 | 1.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.5 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.5 | 1.4 | GO:0098868 | bone growth(GO:0098868) |
0.5 | 0.5 | GO:0060437 | lung growth(GO:0060437) |
0.5 | 4.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.5 | 6.5 | GO:0007416 | synapse assembly(GO:0007416) |
0.5 | 1.4 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 0.9 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.5 | 0.5 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.5 | 0.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.5 | 2.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.5 | 0.5 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.5 | 0.9 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.4 | 3.6 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.4 | 2.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.4 | 1.3 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
0.4 | 0.4 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.4 | 2.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.4 | 0.9 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.4 | 31.9 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.4 | 0.9 | GO:0021764 | amygdala development(GO:0021764) |
0.4 | 1.7 | GO:0016264 | gap junction assembly(GO:0016264) |
0.4 | 0.4 | GO:0019230 | proprioception(GO:0019230) |
0.4 | 1.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.4 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.4 | 1.7 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.4 | 1.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 0.8 | GO:0072170 | metanephric tubule development(GO:0072170) |
0.4 | 1.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.4 | 0.4 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.4 | 0.8 | GO:1902475 | L-alpha-amino acid transmembrane transport(GO:1902475) |
0.4 | 0.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.4 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.4 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.4 | 1.2 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.4 | 0.8 | GO:0043266 | regulation of potassium ion transport(GO:0043266) |
0.4 | 7.5 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.4 | 2.1 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.4 | 0.4 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.4 | 4.9 | GO:0015858 | nucleoside transport(GO:0015858) |
0.4 | 3.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.4 | 1.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.4 | 0.8 | GO:0002434 | immune complex clearance(GO:0002434) |
0.4 | 3.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.4 | 0.4 | GO:0086070 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.4 | 5.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.4 | 1.2 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.4 | 6.8 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.4 | 0.8 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.4 | 1.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.4 | 0.4 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.4 | 2.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.4 | 1.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.4 | 0.8 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.4 | 1.2 | GO:0060914 | heart formation(GO:0060914) |
0.4 | 2.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.4 | 0.4 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.4 | 5.7 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
0.4 | 0.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 6.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.4 | 1.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.4 | 2.6 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.4 | 2.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.4 | 1.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 0.7 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.4 | 0.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.4 | 0.4 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.4 | 0.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 4.8 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.4 | 2.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 1.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.4 | 0.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 1.8 | GO:0015808 | L-alanine transport(GO:0015808) |
0.4 | 2.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.4 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 1.1 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 0.7 | GO:0060004 | reflex(GO:0060004) |
0.3 | 0.7 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 1.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 0.7 | GO:0060005 | vestibular reflex(GO:0060005) |
0.3 | 4.8 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.3 | 2.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 0.3 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
0.3 | 1.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.3 | 1.0 | GO:0048241 | epinephrine transport(GO:0048241) |
0.3 | 2.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.3 | 2.7 | GO:0045056 | transcytosis(GO:0045056) |
0.3 | 4.3 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.3 | 3.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.3 | 0.3 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.3 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
0.3 | 1.3 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 2.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.7 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 2.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.7 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.3 | 2.0 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.3 | 0.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 29.5 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.3 | 0.6 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.3 | 0.3 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.3 | 1.9 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.3 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.3 | 0.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 0.3 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.3 | 1.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.3 | 1.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.3 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
0.3 | 0.3 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.3 | 0.3 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.3 | 0.3 | GO:0050932 | regulation of pigment cell differentiation(GO:0050932) |
0.3 | 2.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.3 | 0.6 | GO:1903726 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) negative regulation of phospholipid metabolic process(GO:1903726) |
0.3 | 0.3 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 0.3 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.3 | 1.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 0.3 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.9 | GO:0048840 | otolith development(GO:0048840) |
0.3 | 0.9 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.3 | 0.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.3 | 1.5 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.3 | 2.6 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.3 | 0.9 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.3 | 0.3 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.3 | 0.6 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 4.4 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 1.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.3 | 0.3 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.3 | 2.0 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 1.4 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 0.6 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.3 | 0.3 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.3 | 0.8 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.3 | 1.1 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.3 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.3 | 2.5 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 0.6 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.9 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.3 | 0.8 | GO:0018343 | protein farnesylation(GO:0018343) |
0.3 | 0.8 | GO:0002176 | male germ cell proliferation(GO:0002176) |
0.3 | 0.5 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.3 | 0.3 | GO:0035483 | gastric emptying(GO:0035483) |
0.3 | 0.5 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.3 | 2.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.3 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.8 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.3 | 0.5 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.3 | 0.3 | GO:2000410 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 3.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 0.8 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.3 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.3 | 1.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.3 | 0.8 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 4.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.3 | 0.3 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.3 | 0.3 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.3 | 0.3 | GO:0001714 | endodermal cell fate specification(GO:0001714) |
0.3 | 1.3 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.3 | 0.3 | GO:0072148 | epithelial cell fate commitment(GO:0072148) |
0.3 | 0.8 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.3 | 1.0 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.5 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.3 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 1.2 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.2 | GO:2000320 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.2 | 1.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.2 | 2.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.2 | 1.2 | GO:0009115 | xanthine catabolic process(GO:0009115) xanthine metabolic process(GO:0046110) |
0.2 | 1.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 0.7 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.2 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.9 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 3.6 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 0.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.2 | 1.9 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.2 | 0.5 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
0.2 | 1.6 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.2 | 2.5 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.2 | 0.2 | GO:0033079 | immature T cell proliferation(GO:0033079) regulation of immature T cell proliferation(GO:0033083) |
0.2 | 0.7 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 0.2 | GO:0070488 | neutrophil aggregation(GO:0070488) |
0.2 | 0.4 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.2 | 0.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.2 | 0.2 | GO:0060157 | urinary bladder development(GO:0060157) |
0.2 | 0.9 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.2 | 0.9 | GO:0042363 | vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) |
0.2 | 0.4 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.2 | 1.3 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.2 | 0.6 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.2 | 1.9 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 5.3 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.2 | 0.4 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.4 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.2 | 1.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.2 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.2 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.6 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.2 | 1.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.2 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.2 | 0.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 1.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.8 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 0.6 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.2 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 0.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.2 | 0.2 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.2 | 1.3 | GO:0045922 | negative regulation of fatty acid metabolic process(GO:0045922) |
0.2 | 0.4 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.2 | GO:0044849 | estrous cycle(GO:0044849) |
0.2 | 0.2 | GO:0002924 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.2 | 1.1 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.5 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 0.2 | GO:0043416 | skeletal muscle satellite cell activation(GO:0014719) regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.2 | 0.4 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 0.5 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 0.4 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.2 | 0.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.2 | 0.5 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.2 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.2 | 1.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
0.2 | 2.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 0.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.2 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.2 | 0.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.5 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.2 | 0.2 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) endocardial cushion formation(GO:0003272) |
0.2 | 0.7 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.7 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.2 | 0.8 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.5 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.2 | 0.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.2 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.2 | 0.2 | GO:0050951 | sensory perception of temperature stimulus(GO:0050951) |
0.2 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.2 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.2 | 1.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 2.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.8 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 0.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.2 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.2 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 2.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.6 | GO:0043584 | nose development(GO:0043584) |
0.2 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.5 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
0.2 | 0.5 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.2 | 0.8 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 1.3 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.1 | 2.8 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.6 | GO:0010460 | positive regulation of heart rate(GO:0010460) |
0.1 | 1.2 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.4 | GO:0046884 | follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.3 | GO:0015755 | fructose transport(GO:0015755) |
0.1 | 0.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.1 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.1 | 1.1 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.5 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.7 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 2.0 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.1 | GO:0003011 | involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.4 | GO:0060065 | uterus development(GO:0060065) |
0.1 | 0.5 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.1 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.4 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 1.0 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0003222 | ventricular trabecula myocardium morphogenesis(GO:0003222) |
0.1 | 0.5 | GO:0001508 | action potential(GO:0001508) |
0.1 | 0.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.2 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.1 | 0.8 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.4 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 3.5 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.1 | 0.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 0.1 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.1 | 0.1 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.1 | 0.2 | GO:0030432 | peristalsis(GO:0030432) |
0.1 | 0.5 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.1 | 0.2 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.2 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.1 | GO:0032650 | regulation of interleukin-1 alpha production(GO:0032650) |
0.1 | 0.2 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.1 | 0.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.1 | 0.4 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 1.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.5 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.5 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.3 | GO:0090154 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.1 | 0.3 | GO:1902074 | response to salt(GO:1902074) |
0.1 | 0.2 | GO:0032610 | interleukin-1 alpha production(GO:0032610) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.3 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 4.0 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.2 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.1 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.2 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 0.3 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.1 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.3 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
0.1 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.1 | 0.2 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.1 | 0.2 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.1 | 0.2 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 0.5 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 | 0.5 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.5 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.4 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.1 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.1 | 0.3 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.2 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.1 | GO:1901535 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.1 | 2.0 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.2 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0060460 | left lung morphogenesis(GO:0060460) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.2 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.1 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.2 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.1 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 0.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 0.2 | GO:0051150 | regulation of smooth muscle cell differentiation(GO:0051150) |
0.1 | 0.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.1 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.0 | 0.1 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.1 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.0 | 1.4 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.0 | 0.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.0 | 0.2 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.0 | 0.0 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.0 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 1.4 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.1 | GO:0071637 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 2.7 | GO:0071773 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.0 | 0.1 | GO:0036491 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.0 | 0.7 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.0 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.0 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.0 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.0 | 0.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.0 | 0.0 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.0 | 0.0 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
0.0 | 0.0 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
0.0 | 0.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.0 | 0.2 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.1 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
0.0 | 0.1 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
0.0 | 0.5 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.1 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.0 | 0.6 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.0 | 0.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
0.0 | 0.1 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.0 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
0.0 | 0.1 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0060750 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.0 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0070525 | tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.0 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.0 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:0002001 | renin secretion into blood stream(GO:0002001) |
0.0 | 0.5 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0045349 | interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.0 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
2.7 | 19.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
2.6 | 10.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
2.5 | 10.1 | GO:0071953 | elastic fiber(GO:0071953) |
2.4 | 12.0 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
2.3 | 7.0 | GO:0005606 | laminin-1 complex(GO:0005606) |
2.3 | 16.0 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
2.2 | 8.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
2.1 | 19.1 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
2.1 | 8.5 | GO:0033010 | paranodal junction(GO:0033010) |
2.0 | 8.0 | GO:0044308 | axonal spine(GO:0044308) |
1.9 | 5.7 | GO:1990812 | growth cone filopodium(GO:1990812) |
1.9 | 7.4 | GO:0043198 | dendritic shaft(GO:0043198) |
1.8 | 21.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.7 | 3.3 | GO:0097427 | microtubule bundle(GO:0097427) |
1.6 | 19.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
1.6 | 16.5 | GO:0001527 | microfibril(GO:0001527) |
1.6 | 4.9 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.6 | 17.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
1.5 | 4.5 | GO:0072534 | perineuronal net(GO:0072534) |
1.5 | 8.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.5 | 10.2 | GO:0045180 | basal cortex(GO:0045180) |
1.5 | 5.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.4 | 24.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.4 | 1.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.4 | 6.8 | GO:0030673 | axolemma(GO:0030673) |
1.3 | 6.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.3 | 15.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.3 | 1.3 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.3 | 16.9 | GO:0032279 | asymmetric synapse(GO:0032279) |
1.3 | 5.1 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.3 | 2.5 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.2 | 12.2 | GO:0043194 | axon initial segment(GO:0043194) |
1.2 | 74.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.2 | 3.5 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
1.1 | 26.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 3.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
1.1 | 2.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 8.3 | GO:0005861 | troponin complex(GO:0005861) |
1.0 | 6.1 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.0 | 7.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.0 | 7.6 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.9 | 16.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.9 | 6.5 | GO:0098644 | complex of collagen trimers(GO:0098644) |
0.9 | 14.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.9 | 8.7 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.9 | 9.4 | GO:0005916 | fascia adherens(GO:0005916) |
0.8 | 2.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 2.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.8 | 22.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.8 | 6.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.7 | 20.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.7 | 6.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 2.2 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 1.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 2.9 | GO:1990696 | USH2 complex(GO:1990696) |
0.7 | 7.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.7 | 15.8 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.7 | 10.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.7 | 2.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.7 | 1.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 1.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.6 | 2.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.6 | 2.4 | GO:0032021 | NELF complex(GO:0032021) |
0.6 | 55.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.6 | 1.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.6 | 1.8 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 1.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 1.8 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 0.6 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.6 | 0.6 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 1.1 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 9.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 84.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.5 | 2.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.5 | 1.6 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.6 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 1.5 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.5 | 1.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 1.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 1.0 | GO:0071437 | invadopodium(GO:0071437) |
0.5 | 1.4 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.5 | 1.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.5 | 2.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.3 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 4.5 | GO:0043034 | costamere(GO:0043034) |
0.4 | 1.2 | GO:0043256 | laminin-5 complex(GO:0005610) laminin complex(GO:0043256) |
0.4 | 2.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.4 | 1.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 15.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 5.4 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.4 | 3.7 | GO:0031512 | motile primary cilium(GO:0031512) |
0.4 | 4.4 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 1.1 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 2.2 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 2.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.4 | 10.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.4 | 3.2 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.4 | 2.9 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.4 | 1.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.3 | 2.7 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 3.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.3 | 0.6 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 17.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 2.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 0.9 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.3 | 1.5 | GO:0071547 | piP-body(GO:0071547) |
0.3 | 1.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.3 | 2.6 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.3 | 61.8 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.3 | 1.9 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.3 | 18.2 | GO:0043204 | perikaryon(GO:0043204) |
0.3 | 18.6 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 3.4 | GO:0001741 | XY body(GO:0001741) |
0.3 | 4.1 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 2.0 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 2.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 0.7 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 0.9 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.2 | 12.6 | GO:0031674 | I band(GO:0031674) |
0.2 | 2.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.2 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 0.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.2 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.8 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.2 | 5.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 0.4 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 5.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.2 | 0.5 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 0.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 2.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.2 | 0.7 | GO:0070820 | tertiary granule(GO:0070820) |
0.2 | 1.2 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 5.3 | GO:0005871 | kinesin complex(GO:0005871) |
0.2 | 0.9 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 4.1 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 5.2 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 1.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.3 | GO:0030427 | site of polarized growth(GO:0030427) |
0.1 | 0.3 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0071797 | LUBAC complex(GO:0071797) |
0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 9.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.2 | GO:0000802 | transverse filament(GO:0000802) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.6 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 0.6 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.1 | 0.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 0.2 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 2.0 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 1.4 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 0.2 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 0.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.3 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.3 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 3.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.2 | GO:1990745 | EARP complex(GO:1990745) |
0.0 | 8.4 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.0 | 0.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 0.3 | GO:0036157 | axonemal dynein complex(GO:0005858) outer dynein arm(GO:0036157) |
0.0 | 0.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.1 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.2 | 21.1 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
4.0 | 12.1 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.2 | 6.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.1 | 9.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
3.1 | 15.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
2.9 | 14.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.8 | 8.4 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
2.8 | 8.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
2.8 | 8.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
2.6 | 10.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.4 | 17.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.4 | 9.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.4 | 11.9 | GO:0070051 | fibrinogen binding(GO:0070051) |
2.4 | 9.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
2.4 | 7.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.3 | 7.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
2.3 | 7.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
2.2 | 10.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.1 | 4.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.1 | 16.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.0 | 8.0 | GO:0071253 | connexin binding(GO:0071253) |
2.0 | 7.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.9 | 9.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
1.9 | 7.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.8 | 7.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.8 | 7.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
1.8 | 5.4 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.8 | 7.0 | GO:0038064 | collagen receptor activity(GO:0038064) |
1.8 | 12.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.7 | 3.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.7 | 15.4 | GO:0031432 | titin binding(GO:0031432) |
1.7 | 8.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
1.7 | 5.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.7 | 11.6 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.7 | 19.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.7 | 8.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.6 | 4.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.6 | 11.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
1.6 | 6.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.6 | 4.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
1.6 | 20.5 | GO:0031005 | filamin binding(GO:0031005) |
1.5 | 13.9 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.5 | 7.6 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.5 | 3.0 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.5 | 4.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
1.5 | 5.9 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
1.5 | 4.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.4 | 11.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
1.4 | 1.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
1.3 | 1.3 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
1.3 | 4.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
1.3 | 17.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.3 | 5.0 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
1.2 | 1.2 | GO:0055100 | adiponectin binding(GO:0055100) |
1.2 | 6.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.2 | 3.5 | GO:0030172 | troponin C binding(GO:0030172) |
1.1 | 4.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.1 | 3.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 3.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.1 | 5.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
1.1 | 16.6 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
1.1 | 4.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
1.1 | 8.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.0 | 6.2 | GO:0048495 | Roundabout binding(GO:0048495) |
1.0 | 3.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.0 | 3.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.0 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.0 | 3.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
1.0 | 4.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.0 | 10.7 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.0 | 3.9 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.9 | 3.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.9 | 4.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.9 | 2.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.9 | 5.5 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.9 | 3.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 2.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.9 | 4.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.9 | 7.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.9 | 4.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.9 | 17.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.9 | 5.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 4.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.9 | 3.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.9 | 1.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.9 | 11.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.9 | 1.7 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.8 | 2.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 1.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.8 | 13.5 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.8 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 6.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 8.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.8 | 10.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.8 | 3.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.8 | 4.0 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.8 | 26.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.8 | 10.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.8 | 4.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.8 | 15.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.8 | 4.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.8 | 2.3 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.8 | 3.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.8 | 2.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.8 | 8.5 | GO:0005522 | profilin binding(GO:0005522) |
0.8 | 3.1 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.8 | 2.3 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.8 | 22.7 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.8 | 2.3 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.7 | 1.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.7 | 11.2 | GO:0030553 | cGMP binding(GO:0030553) |
0.7 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 3.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.7 | 3.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 4.4 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.7 | 0.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.7 | 5.8 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.7 | 22.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.7 | 5.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 17.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.7 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.7 | 5.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.7 | 2.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 1.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.7 | 2.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.7 | 2.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.7 | 4.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 2.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.7 | 17.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 0.7 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.7 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.7 | 2.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.7 | 3.3 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.7 | 2.0 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.7 | 4.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.7 | 15.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.7 | 13.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.7 | 18.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.6 | 3.2 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.6 | 7.7 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.6 | 5.1 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.6 | 1.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 3.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.6 | 1.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.6 | 4.3 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.6 | 1.8 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.6 | 7.8 | GO:0015026 | coreceptor activity(GO:0015026) |
0.6 | 2.4 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 1.8 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.6 | 12.5 | GO:0005272 | sodium channel activity(GO:0005272) |
0.6 | 4.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.6 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 1.7 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.7 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.6 | 1.7 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.6 | 7.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.6 | 1.7 | GO:0004096 | catalase activity(GO:0004096) |
0.6 | 4.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.6 | 7.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.6 | 1.7 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.6 | 1.7 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.5 | 7.1 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 7.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.5 | 2.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.5 | 3.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 5.3 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.5 | 1.1 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.5 | 2.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.5 | 1.6 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 6.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.5 | 3.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.5 | 4.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.5 | 2.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 3.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 1.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 4.0 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.5 | 9.8 | GO:0003785 | actin monomer binding(GO:0003785) |
0.5 | 1.4 | GO:0016015 | morphogen activity(GO:0016015) |
0.5 | 1.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 2.9 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.5 | 2.9 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.5 | 8.4 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 1.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.5 | 7.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.4 | 0.4 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 1.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.4 | 0.4 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.4 | 9.2 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.4 | 1.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.4 | 1.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 1.6 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 2.0 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.4 | 1.2 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.4 | 1.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.4 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 1.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.4 | 37.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 0.7 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.4 | 2.5 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 13.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 4.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.4 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 1.8 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.4 | 1.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.3 | 8.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 2.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 1.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 10.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.3 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.3 | 4.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.3 | 1.0 | GO:0035939 | microsatellite binding(GO:0035939) |
0.3 | 8.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 1.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.3 | 1.0 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 1.3 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.3 | 12.3 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.3 | 4.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 3.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 4.3 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.3 | 0.3 | GO:0015186 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.3 | 2.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.6 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.3 | 7.1 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 0.9 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 1.5 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.3 | 2.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.3 | 1.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 2.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 1.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.3 | 8.7 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 2.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 0.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 0.3 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.3 | 0.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 2.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.3 | 0.3 | GO:0038191 | neuropilin binding(GO:0038191) |
0.3 | 0.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 3.0 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.2 | GO:0004854 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.2 | 1.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.2 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.2 | 1.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.2 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.7 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.2 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.2 | 1.0 | GO:0048185 | activin binding(GO:0048185) |
0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.2 | 3.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 0.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.2 | 2.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.2 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.6 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.2 | 3.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.2 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.2 | 1.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.2 | 1.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.2 | 1.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 0.4 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.2 | 1.0 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 3.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 0.6 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 1.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.2 | 2.7 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 10.4 | GO:0005178 | integrin binding(GO:0005178) |
0.2 | 1.7 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 2.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 2.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 2.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 2.4 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.2 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.2 | 0.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 0.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 4.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 2.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.2 | 2.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.2 | 1.2 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 0.3 | GO:0051425 | PTB domain binding(GO:0051425) |
0.2 | 0.7 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 1.7 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 0.5 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 3.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.2 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 0.8 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.1 | GO:0008688 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 0.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 0.8 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 1.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
0.1 | 0.7 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.1 | 0.4 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.6 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.1 | 1.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.4 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 1.5 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 7.3 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.1 | 4.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.1 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 0.5 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
0.1 | 9.5 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 2.9 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.1 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 25.9 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.3 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.3 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.2 | GO:0030519 | snoRNP binding(GO:0030519) |
0.1 | 0.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.9 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 0.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.1 | GO:0016662 | oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) |
0.1 | 1.5 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.1 | 0.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.4 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 8.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 5.0 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 1.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 1.1 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.6 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 3.6 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 0.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.1 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 0.5 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.6 | GO:0005416 | cation:amino acid symporter activity(GO:0005416) |
0.1 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 1.5 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 0.1 | GO:0051380 | norepinephrine binding(GO:0051380) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 0.1 | GO:0033612 | receptor serine/threonine kinase binding(GO:0033612) |
0.1 | 0.3 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.3 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 0.2 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 0.6 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.0 | 0.1 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.0 | 0.0 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 1.0 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 5.6 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.2 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.4 | 1.4 | PID IGF1 PATHWAY | IGF1 pathway |
1.4 | 5.5 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
1.4 | 1.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.2 | 19.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.2 | 51.4 | NABA COLLAGENS | Genes encoding collagen proteins |
1.1 | 30.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.0 | 1.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.0 | 10.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 1.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.8 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.8 | 14.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.8 | 1.5 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.7 | 15.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.7 | 6.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.7 | 25.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 7.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 11.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.6 | 0.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 4.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 10.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 1.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.6 | 17.0 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.6 | 17.9 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.6 | 22.4 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.6 | 91.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 13.1 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 11.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 3.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.4 | 13.3 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 2.4 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.4 | 4.9 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.4 | 5.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 3.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 2.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 0.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.3 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.3 | 5.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 6.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.3 | 1.2 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 0.6 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 9.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 4.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 5.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 2.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 1.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 8.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 0.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 6.9 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 51.7 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 1.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 5.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.2 | 3.7 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.2 | 2.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 3.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 2.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 0.7 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 2.3 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 5.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 12.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 1.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.9 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.2 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 31.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.0 | 29.7 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.0 | 2.0 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.9 | 21.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
1.6 | 3.2 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.5 | 60.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.5 | 52.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.4 | 1.4 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.3 | 2.7 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
1.2 | 12.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
1.1 | 49.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.1 | 12.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
1.0 | 23.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 1.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.9 | 31.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 3.4 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.8 | 11.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.8 | 9.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 1.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.8 | 0.8 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.8 | 15.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.7 | 17.4 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 8.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.7 | 5.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.6 | 7.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 1.9 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.6 | 1.8 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 6.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.6 | 6.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.6 | 10.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 15.2 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.5 | 2.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.5 | 4.9 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.5 | 24.2 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.5 | 3.7 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 6.8 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.4 | 5.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.4 | 2.2 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 11.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 3.8 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 0.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.4 | 10.3 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.4 | 0.8 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.4 | 2.4 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.4 | 3.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.4 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.4 | 1.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.3 | 3.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 7.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.3 | 7.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.3 | 2.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.3 | 6.0 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.3 | 0.3 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 5.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.3 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.3 | 0.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.3 | 4.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 2.8 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.3 | 0.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 2.8 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 3.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 1.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 1.2 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 0.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 7.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 0.4 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 5.2 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.2 | 2.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.2 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 1.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.9 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.5 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.1 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.1 | 0.3 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 2.4 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.5 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 2.0 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.9 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.0 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.1 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 3.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.0 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.1 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.1 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |